ROBERT LABRIL M.D.
Prescription History 1255867255
Psychiatry & Neurology - Child & Adolescent Psychiatry in New Haven, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ROBERT LABRIL M.D., an active Child & Adolescent Psychiatry specialist practicing in New Haven, CT. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 16 documented patient claims. Among these therapy options, the most frequently utilized medication is Fluvoxamine Maleate, which accounts for 16 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Fluvoxamine Maleate | 16 | $24.38▼ below CT avg | ▼ Less than typical |
About Fluvoxamine Maleate: This medication is used to treat obsessive-compulsive disorder (OCD). Show more ▾ Fluvoxamine belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS. In 2024, this provider wrote 16 Medicare prescriptions for Fluvoxamine Maleate, about half the volume of the typical Connecticut prescriber of this medication (28.5). Medicare paid an average of $24.38 per fill, versus $37.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 28 30-Day Fills standardized to 30-day supplies 814 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for ROBERT LABRIL M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Child & Adolescent Psychiatry prescribing approach at this New Haven, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
